Full Name
Koh Chee Liang, Stephen
(not current staff)
Variants
Koh, S.C.L.
Kohsc, L.
Kohcl, S.
Koh, C.L.S.
Koh, C.S.
Koh, S.C.
Koh, S.
 
Main Affiliation
 
 
Email
obgkohcl@nus.edu.sg
 

Publications

Results 21-40 of 43 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
21May-1996Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcomeTomer, Y.; Viegas, O.A.C. ; Swissa, M.; Koh, S.C.L. ; Shoenfeld, Y.
221996Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcomeTomer, Y.; Swissa, M.; Shoenfeld, Y.; Viegas, O.A.C. ; Koh, S.C.L. 
231992Plasma urokinase activity and antigen levels in normal males, females and in late pregnancyKoh, S.C.L. ; Yuen, R. ; Viegas, O.A.C. ; Ratnam, S.S. 
241992Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal periodKoh, C.L.S. ; Viegas, O.A.C. ; Yuen, R. ; Chua, S.E.; Ng, B.L.; Ratnam, S.S. 
251996Plasminogen activators and inhibitors, D-dimer and β-TG in systemic lupus erythematosus pregnancy in relation to their obstetric outcomeKoh, S.C.L. ; Boey, M.L.; Ratnam, S.S. ; Viegas, O.A.C. 
261987Plasminogen activators in the endometrium; a preliminary study in subfertile subjectsKoh, S.C.L. ; Wong, P.C. ; Yuen, R. 
271987Plasminogen activators in the endometrium; a preliminary study in subfertile subjectsKoh, S.C.L. ; Wong, P.C.; Yuen, R. 
281991Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and femalesKoh, S.C.L. ; Yuen, R. ; Viegas, O.A.C. ; Chua, S.E. ; Ng, B.L. ; Sen, D.K. ; Ratnam, S.S. 
291993Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsiaKoh, S.C.L. ; Anandakumar, C. ; Montan, S. ; Ratnam, S.S. 
301998Preeclampsia: Haemostatic status and the short-term effects of methyldopa and isradipine therapyYin, K.H.; Koh, S.C.L. ; Biswas, A. ; Arulkumaran, S. ; Ratnam, S.S. ; Malcus, P.; SvenMontan, S.
311998Preliminary study of uPAR and plasminogen activators and inhibitors in tissues from benign and ovarian cancerKohsc, L. ; Tham, K.F. ; Razvik, L.; Oe, P.L. 
322006The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancerKoh, S.C.L. ; Khalil, R.; Lim, F.-K.; Ilancheran, A. ; Choolani, M. 
332007The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagiaKoh, S.C.L. ; Singh, K. 
341980The effect of long-term steroid contraception on coagulation in Asian womenTsakok, F.H.M.; Ho, L.M.; Koh, S. ; Ratnam, S.S. 
351988The effect of Norplant®-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: Haemostatic changesSingh, K. ; Viegas, O.A.C. ; Koh, S. ; Singh, P. ; Ratman, S.S. 
361995The effects of gynaecological surgery on coagulation activation, fibrinolysis and fibrinolytic inhibitor in patients with and without ketorolac infusionKoh, S.C.L. ; Pua, H.L.; Ratnam, S.S. ; Tay, D.H.B.
371998The effects of long-term hormone-replacement therapy on coagulation, fibrinolysis and inhibitors in postmenopausal womenKoh, S.C.L. ; Dramusic, V. ; Shan, Ratnam S. 
381988The effects of Norplant® on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changesViegas, O.A.C. ; Singh, K. ; Koh, S. ; Singh, P. ; Ratnam, S.S. 
391996The effects of reformulated 2-rod Norplant® implant on hemostasis after three yearsViegas, O.A.C. ; Koh, S.C.L. ; Ratnam, S.S. 
40Oct-1998The influence of labor and placental separation on hemostasis in term pregnancyKoh, S.C.L. ; Arulkumaran, S. ; Biswas, A. ; Ratnam, S.S.